Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in conjunction with Cytoreductive Surgery (CRS) is a proven cancer treatment for Peritoneal Surface Malignancy (PSM). Watch the experts in the field discuss this vital therapy.
*Dr. Ali Alsaffar of The Kuwait Hospital on Peritoneal Surface Malignancy
*Dr. Rajesh Nair of MD Anderson Cancer Center in Orlando, FL on Cytoreductive Surgery and HIPEC
*Dr. Richard Berri, Director of Surgical Oncology at Elslander Cancer Center at St. John Hospital in Detroit Michigan on CRS + HIPEC and PSM
*Dr. Nader Hanna, Head of Surgical Oncology at Marlene & Steward Greenebaum Cancer Center at the University of Maryland on CRS + HIPEC
*Dr. C. William Helm of the James Graham Brown Cancer Center in Louisville, Kentucky on HIPEC in Ovarian Cancer